Effect of CRH on NO bioavailability, ROS production and antioxidant defense systems in endothelial EAhy926 cells

References

• Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981;213: 1394–1397.
   PubMed Web of Science ®Google Scholar
• Karalis K, Sano H, Redwine J, Listwak S, Wilder RL, Chrousos GP. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 1991;254: 421–423.
   PubMed Web of Science ®Google Scholar
• Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE, Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995;378:287–292.
   PubMed Web of Science ®Google Scholar
• Chen R, Lewis KA, Perrin MH, Vale WW. Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 1993;90:8967–8971.
   PubMed Web of Science ®Google Scholar
• Kishimoto T, Pearse RV, Lin CR, Rosenfeld MG. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Si USA 1995;92: 1108–1112.
   PubMed Web of Science ®Google Scholar
• Lovenberg TW, Chalmers DT, Liu C, De Souza EB. CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 1995;13:4139–4142.
   Google Scholar
• Perrin M, Donaldson C, Chen R, Blount A, Berggren T, Bilezikjian L, Sawchenko P, Vale W. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci USA 1995;92:2969–2973.
   PubMed Web of Science ®Google Scholar
• Stenzel P, Kesterson R, Yeung W, Cone RD, Rittenberg MB, Stenzel-Poore MP. Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. Mol Endocrinol 1995;9:637–645.
   PubMedGoogle Scholar
• Grigoriadis DE, Lovenberg TW, Chalmers D, Liaw C, De Souza EB. Characterization of corticotropin-releasing factor receptor subtypes. Ann N Y Acad Sci 1996;780:60–80.
   PubMed Web of Science ®Google Scholar
• Potter E, Sutton S, Donaldson C, Chen R, Perrin M, Lewis K, Sawchenko PE, Vale W. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA 1994;91:8777–8781.
   PubMed Web of Science ®Google Scholar
• Chalmers DT, Lovenberg TW, De Souza EB. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 1995;15:6340–6350.
   PubMed Web of Science ®Google Scholar
• Zoumakis E, Rice KC, Gold PW, Chrousos GP. Potential uses of corticotropin-releasing hormone antagonists. Ann N Y Acad Sci 2006;1083:239–251.
   PubMed Web of Science ®Google Scholar
• Grammatopoulos DK, Chrousos GP. Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol Metab 2002;13:436–444.
   PubMed Web of Science ®Google Scholar
• Webster EL, Lewis DB, Torpy DJ, Zachman EK, Rice KC, Chrousos GP. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotrophin-releasing hormone receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology 1996;137:5747–5750.
   PubMed Web of Science ®Google Scholar
• Hillhoude E, Grammatopoulos DK. The molecular mechanisms underlying the regulation of the biological activity of corticotropn-releasing hormone receptors: implications for physiology and pathophysiology. Endocr Rev 2006;27: 260–286.
   PubMed Web of Science ®Google Scholar
• Sessa WC. The nitric oxide synthase family of proteins. Br J Pharmacol 1994;31:131–143.
   Google Scholar
• Huang AL, Vita JA. Effects of systemic inflammation on endothelium-dependent vasodilation. Trends Cardiovasc Med 2006;16:15–20.
   PubMed Web of Science ®Google Scholar
• Widlansky ME, Gokce N, Keaney JF, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003;42:1149–1160.
   PubMed Web of Science ®Google Scholar
• Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004;266:37–56.
   PubMed Web of Science ®Google Scholar
• Mates JM, Perez-Gomez C, De Castro IN. Antioxidant enzymes and human diseases. Clin Biochem 1999;32: 595–603.
   PubMed Web of Science ®Google Scholar
• Simoncini T, Apa R, Reis FM, Miceli F, Stomati M, Driul L, Lanzone A, Genazzani AR, Petraglia F. Human umbilical vein endothelial cells: a new source and potential target for corticotropin-releasing factor. J Clin Endocrinol Metab 1999;84:2802–2806.
   PubMed Web of Science ®Google Scholar
• Dashwood MR, Andrews HE, Wei ET. Binding of [125]Tyr-corticotropin-releasing factor to rabbit aorta is reduced by removal of the endothelium. Eur J Pharmacol 1987;135: 111–112.
   PubMed Web of Science ®Google Scholar
• Cantarella G, Lempereur L, Lombardo G, Chiarenza A, Pafumi C, Zappala G, Bernardini R. Divergent effects of corticotropin releasing hormone on endothelial cell nitric oxide synthase are associated with different expression of CRH type 1 and 2 receptors. Br J Pharmacol 2001;134:837–844.
   PubMed Web of Science ®Google Scholar
• Inada Y, Ikeda K, Tojo K, Sakamoto M, Takada Y, Tajima N. Possible involvement of corticotropin-releasing factor receptor signaling on vascular inflammation. Peptides 2009;30: 365–372.
   PubMed Web of Science ®Google Scholar
• Edgell CJ, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridisation. Proc Natl Acad Sci USA 1983;80:3734–3737.
   PubMed Web of Science ®Google Scholar
• Knowles RG, Palacios M, Palmer RM, Moncada S. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase Proc Natl Acad Sci USA 1989;86:5159–5162.
   PubMed Web of Science ®Google Scholar
• Stuehr DJ, Kwon NS, Nathan CF, Griffith OW, Feldman PL, Wiseman J. N omega-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J Biol Chem 1991;266:6259–6263.
   PubMed Web of Science ®Google Scholar
• Pollock JS, Förstermann U, Mitchell JA, Warner TD, Schmidt HH, Nakane M, Murad F. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA 1991;88:10480–10484.
   PubMed Web of Science ®Google Scholar
• Aebi H. Catalase in vitro. Methods Enzymol 1984;105: 121–126.
   PubMed Web of Science ®Google Scholar
• Chakrapani B, Yedavally S, Leverenz V, Giblin FJ, Reddy VN. Simultaneous measurement of reduced and oxidized glutathione in human aqueous humor and cataracts by electrochemical detection. Ophthalmic Res 1995;27:69–77.
   PubMed Web of Science ®Google Scholar
• Shaik IH, Mehvar R. Rapid determination of reduced and oxidized glutathione levels using a new thiol-masking reagent and the enzymatic recycling method: application to the rat liver and bile samples. Anal Bioanal Chem 2006;385:105–113.
   PubMed Web of Science ®Google Scholar
• Ruckert Y, Rohde W, Furkert J. Radioimmunoassay of corticotrophin releasing hormone. Exp Clin Endocrinol 1990;96:129–137.
   PubMedGoogle Scholar
• Jain V, Vedernikov YP, Saade GR, Chwalisz K, Garfield RE. The relaxation responses to corticotropin-releasing factor in rat aorta are endothelium dependent and gestationally regulated. Am J Obstet Gynecol 1997;176:234–240.
   PubMed Web of Science ®Google Scholar
• Jain V, Vedernikov YP, Saade GR, Chwalisz K, Garfield RE. Endothelium-dependent and -independent mechanisms of vasorelaxation by corticotropin-releasing factor in pregnant rat uterine artery. J Pharmacol Exp Ther 1999;288: 407–413.
   PubMed Web of Science ®Google Scholar
• Clifton VL, Read MA, Leitch IM, Giles WB, Boura AL, Robinson PJ, Smith R. Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3’,5’-monophosphate-mediated pathway. J Clin Endocrinol Metab 1995;80:2888–2893.
   PubMed Web of Science ®Google Scholar
• Lei S, Richter R, Bienert M, Mulvany MJ. Relaxing actions of corticotropin-releasing factor on rat resistance arteries. Br J Pharmacol 1993;108:941–947.
   PubMed Web of Science ®Google Scholar
• Wilbert-Lampen U, Straube F, Trapp A, Deutschmann A, Plasse A, Steinbeck G. Effects of corticotropin-releasing hormone (CRH) on monocyte function, mediated by CRH-receptor subtype R1 and R2: a potential link between mood disorders and endothelial dysfunction? J Cardiovasc Pharmacol 2006;47:110–116.
   PubMed Web of Science ®Google Scholar
• Poli G, Leonarduzzi G, Biasi F, Chiarpotto E. Oxidative stress and cell signalling. Curr Med Chem 2004;11:1163–1182.
   PubMed Web of Science ®Google Scholar
• Stuehr D, Pou S, Rosen GM. Oxygen reduction by nitric-oxide synthases. Biol Chem 2001;18:14533–14536.
   Google Scholar
• Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BSS, Karoui H, Tordo P, Prithard KA Jr. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors. Proc Natl Acad Sci USA 1998;95:9220–9225.
   PubMed Web of Science ®Google Scholar
• Wiley KE, Davenport AP. CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators. Br J Pharmacol 2004;143:508–514.
   PubMed Web of Science ®Google Scholar
• Pritchard KA Jr, Groszek L, Smalley DM, Sessa WC, Wu M, Villalon P, Wolin MS, Stemmerman MB. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res 1995;77: 510–518.
   PubMed Web of Science ®Google Scholar
• Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, Harrison DG. Endothelial regulation of vasomotion in apoE-deficient mice implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 2001;103:1282–1288.
   PubMed Web of Science ®Google Scholar
• Ramprasad VR, Shanthi P, Sachdanandam P. Evaluation of antioxidant effect of Semecarpus anacardium Linn.nut extract on the components of immune system in adjuvants arthritis. Vasc Pharmacol 2005;42:179–186.
   PubMed Web of Science ®Google Scholar
• Benhamou PY, Moriscot C, Richard MJ, Beatrix O, Badet L, Pattou F, Kerr-Conte J, Chroboczek J, Lemarchand P, Halimi S. Adenovirus-mediated catalase gene transcription reduces oxidant stress in human, porcine and rat pancreatic islets. Diabetologia 1998;41:1093–1100.
   PubMed Web of Science ®Google Scholar
• Correa SG, Riera CM, Spiess J, Bianco ID. Modulation of the inflammatory response by corticotropin-releasing factor. Eur J Pharmacol 1997;319:85–90.
   PubMed Web of Science ®Google Scholar